| Literature DB >> 35159557 |
Anna Puścion-Jakubik1, Ewa Olechno2, Katarzyna Socha1, Małgorzata Elżbieta Zujko2.
Abstract
The coronavirus 19 (COVID-19) pandemic has brought many changes in terms of lifestyle, education, stress levels, and social contacts. The aim of our research was to evaluate changes in eating habits, physical activity, and selected lifestyle elements in a group of school staff, as well as their immune response to vaccination against COVID-19, and FRAP (ferric reducing antioxidant power) level. In total, 108 primary school teachers and other school staff with integration departments were included in the study. An original survey was conducted with the school staff. Of the study group, 45.4% chose to be vaccinated against COVID-19. In this group, the level of IgG antibodies was assessed, as well as the level of FRAP before vaccination, and after the first and second dose. An original questionnaire was also carried out. A decrease in physical activity and an increase in the time spent in front of the computer have been demonstrated, but a positive observation was a favorable change in most eating habits. After the second dose of vaccination, all subjects achieved the appropriate level of IgG antibodies (above 22 U/mL), with the maximum level recorded in 51%. There was also a significant increase in FRAP levels in the group after the first and second dose of the vaccine compared to the baseline level; an issue that requires further observation.Entities:
Keywords: Poland; antioxidants; diet; lifestyle
Year: 2022 PMID: 35159557 PMCID: PMC8834520 DOI: 10.3390/foods11030408
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Study scheme. FRAP: ferric reducing antioxidant potential.
Characteristics of the study group (n = 108).
| Parameter |
| Av. ± SD | Med. | Min.–Max | Q1–Q3 |
|---|---|---|---|---|---|
| Gender ( | 89/19 | - | - | - | - |
| Age (years) | 108 | 46.3 ± 10.5 | 48.5 | 24.0–70.0 | 39.5–54.0 |
| Height (m) | 108 | 168.0 ± 6.6 | 168.0 | 153.0–190.0 | 163.0–170.5 |
| Body weight (kg) | 108 | 74.0 ± 13.5 | 70.0 | 55.0–115.0 | 63.0–83.0 |
| BMI (kg/m2) | 108 | 26.3 ± 4.3 | 25.6 | 19.3–41.7 | 23.0–29.1 |
| Work experience (years) | 108 | 16.6 ± 12.1 | 17.5 | 0.5–51.0 | 4.5–20.5 |
Av.—average, M—men, Max—maximum, Med.—median, Min.—minimum, Q1–Q3—quartile 1–quartile 3, SD—standard deviation, W—women.
Baseline characteristic of study groups (n = 108).
| Parameter | Total ( | Women ( | Men ( |
|---|---|---|---|
| Change in weight during a pandemic | |||
| No change | 51 (47.2) | 41 (46.1) | 10 (52.5) |
| It was increased in the range of 3–5 kg | 42 (39.0) | 36 (40.4) | 6 (31.6) |
| It was increased in the range above 10 kg | 5 (4.6) | 4 (4.5) | 1 (5.3) |
| It was reduced in the range of 3–5 kg | 1 (0.9) | 0 (0.0) | 1 (5.3) |
| It was reduced in the range of 6–10 kg | 8 (7.4) | 7 (7.9) | 1 (5.3) |
| It was reduced in the range above 10 kg | 1 (0.9) | 1 (1.1) | 0 (0.0) |
| Type of work performed at school (multiple choice question) | |||
| Teacher in grades 0–3 | 40 (37.0) | 38 (42.7) | 2 (10.5) |
| Teacher in grades 4–8 | 33 (30.6) | 23 (25.8) | 10 (52.6) |
| School administration | 10 (9.3) | 8 (9.0) | 2 (10.5) |
| School service | 29 (26.9) | 24 (27.0) | 5 (26.4) |
| How do you currently work? | |||
| Stationary | 55 (51.4) | 48 (53.9) | 7 (36.8) |
| Remotely | 21 (18.7) | 13 (14.6) | 8 (42.1) |
| Stationary and remotely | 32 (29.9) | 28 (31.5) | 4 (21.1) |
| How do you rate remote learning during a pandemic? | |||
| Comparable to traditional teaching | 16 (14.6) | 14 (15.7) | 2 (10.5) |
| Worse than traditional education | 92 (85.4) | 75 (84.3) | 17 (89.5) |
Experiences with COVID-19 among study group (n = 108).
| Parameter | Total ( | Women ( | Men ( |
|---|---|---|---|
| Have you been tested positive for COVID-19? | |||
| Yes | 23 (21.3) | 23 (25.8) | 0 (0.0) |
| No | 85 (78.7) | 66 (74.2) | 19 (100.0) |
| Have you had a COVID-19 antibody test performed? | |||
| Yes | 8 (7.4) | 8 (9.0) | 0 (0.0) |
| No | 100 (92.6) | 81 (91.0) | 19 (100.0) |
| If you have had COVID-19, please mark the symptoms accompanying the disease (multiple choice question) | |||
| Fever of 38 °C and above | 11 (10.2) | 10 (11.2) | 1 (5.3) |
| Cough | 10 (9.3) | 9 (10.1) | 1 (5.3) |
| Diarrhea | 3 (2.8) | 3 (3.4) | 0 (0.0) |
| Nausea | 4 (3.7) | 4 (4.5) | 0 (0.0) |
| Vomiting | 1 (0.9) | 1 (1.1) | 0 (0.0) |
| Smell and taste disorders | 16 (14.8) | 15 (16.9) | 0 (0.0) |
| Conjunctivitis | 1 (0.9) | 1 (1.1) | 0 (0.0) |
| Difficulty breathing, difficulty drawing air | 7 (6.5) | 7 (7.9) | 0 (0.0) |
| Muscle aches, fatigue | 15 (13.9) | 14 (15.7) | 1 (5.3) |
| Other symptoms | 7 (6.5) | 7 (7.9) | 0 (0.0) |
| Have any of your household members had a positive COVID-19 test? | |||
| Yes | 14 (13.0) | 8 (9.0) | 6 (31.6) |
| No | 94 (87.0) | 81 (91.0) | 13 (68.4) |
| Were you in quarantine because of COVID-19? | |||
| Yes | 36 (33.3) | 29 (32.6) | 7 (36.8) |
| No | 72 (66.7) | 60 (67.4) | 12 (63.2) |
| For what reason were you in quarantine? (38 answers) | |||
| Own disease | 6 (5.6) | 6 (6.7) | 0 (0.0) |
| Household disease | 15 (13.9) | 11 (12.4) | 4 (21.1) |
| Co-worker disease | 10 (9.3) | 7 (7.9) | 3 (15.8) |
| Return from abroad | 2 (1.9) | 2 (2.2) | 0 (0.0) |
| Another | 5 (4.6) | 5 (5.6) | 0 (0.0) |
| Do you suffer from chronic diseases? | |||
| Yes | 37 (34.3) | 34 (38.2) | 3 (15.8) |
| No | 71 (65.7) | 55 (61.8) | 16 (84.2) |
| Have you been vaccinated against COVID-19? | |||
| No | 109 (100.0) | 89 (100.0) | 19 (100.0) |
| Yes | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Would you report your willingness to be vaccinated against COVID-19 if it was possible? | |||
| Yes | 61 (56.5) | 47 (52.8) | 14 (73.7) |
| No | 47 (43.5) | 42 (47.2) | 5 (26.3) |
| If not, why not? (30 answers) | |||
| I don’t believe vaccination is effective | 3 (2.8) | 2 (2.2) | 1 (5.3) |
| I do not like the type of vaccine offered to the education staff | 20 (18.5) | 17 (19.1) | 3 (15.8) |
| Other | 7 (6.5) | 7 (7.9) | 0 (0.0) |
| If you have had COVID-19, do you think that your current health has returned to its pre-disease state? (23 answers) | |||
| Yes | 6 (5.6) | 6 (6.7) | 0 (0.0) |
| No | 17 (15.7) | 14 (15.7) | 3 (15.8) |
| If you have suffered from COVID-19, what complications do you experience after the illness? (35 answers) | |||
| General | 7 (6.5) | 7 (7.9) | 0 (0.0) |
| From the respiratory system | 5 (4.6) | 5 (5.6) | 0 (0.0) |
| From the cardiovascular system | 6 (5.6) | 6 (6.7) | 0 (0.0) |
| Neurological and psychiatric | 8 (7.4) | 8 (9.0) | 0 (0.0) |
| From the gastrointestinal tract | 1 (0.9) | 1 (1.1) | 0 (0.0) |
| From the motor organ | 3 (2.8) | 3 (3.4) | 0 (0.0) |
| From the sensory organs and the throat | 5 (4.6) | 4 (4.5) | 1 (5.3) |
COVID-19—coronavirus disease.
Lifestyle changes during a pandemic (n = 108).
| Parameter | Total ( | Women ( | Men ( |
|---|---|---|---|
| Do you feel stress related to the pandemic? | |||
| Yes | 84 (77.8) | 71 (79.8) | 13 (68.4) |
| No | 24 (22.2) | 18 (20.2) | 6 (31.6) |
| What is the stress experienced during a pandemic related to? (multiple choice question) | |||
| Concern for own and family’s health | 88 (81.5) | 73 (82.0) | 15 (78.9) |
| Limited social life | 42 (38.9) | 36 (40.4) | 6 (31.6) |
| Care for job stability and earnings | 31 (28.7) | 26 (29.2) | 5 (26.3) |
| Online learning and limited access to computer hardware | 18 (16.7) | 17 (19.1) | 1 (5.3) |
| Concern for the level of the teaching of their students | 46 (42.6) | 40 (44.9) | 6 (31.6) |
| Other | 2 (1.9) | 2 (2.2) | 0 (0.0) |
| How have your hygiene habits changed during the pandemic? (multiple choice question) | |||
| They have not changed | 15 (13.9) | 13 (14.6) | 2 (10.5) |
| I wash my hands more often | 72 (66.7) | 59 (66.3) | 13 (68.4) |
| I disinfect my hands more often | 79 (73.1) | 66 (74.2) | 13 (68.4) |
| I wear the mask in public places | 93 (86.1) | 76 (85.4) | 15 (78.9) |
| Other | 3 (2.8) | 2 (2.2) | 0 (0.0) |
| Do you smoke cigarettes? | |||
| Yes, regularly | 8 (7.4) | 3 (3.4) | 5 (26.3) |
| Yes, occasionally | 4 (3.7) | 3 (3.4) | 1 (5.3) |
| No | 95 (88.0) | 83 (93.2) | 12 (63.1) |
| I have smoked, but quit during the pandemic | 1 (0.9) | 0 (0.0) | 1 (5.3) |
| How do you evaluate the change in eating habits during the pandemic? | |||
| Positive change | 22 (20.4) | 20 (22.5) | 2 (10.5) |
| Negative change | 20 (18.5) | 13 (14.6) | 6 (31.6) |
| No change | 66 (61.1) | 55 (62.9) | 11 (57.9) |
Physical activity before and during a pandemic (n = 108).
| Physical Activity | Before the Pandemic * | During a Pandemic |
|---|---|---|
| Lack of physical activity | 23 (21.3) | 38 (35.2) |
| 1–2 times a week, minimum 30 min | 43 (39.9) | 42 (38.9) |
| 3–5 times a week, minimum 30 min | 25 (23.1) | 17 (15.7) |
| More than 5 times a week, minimum 30 min | 17 (15.7) | 11 (10.2) |
* p < 0.05—statistically significant differences between groups.
Changes in product consumption during a pandemic (n = 108).
| Product | Increase | Decrease |
|---|---|---|
| Fruits, vegetables, salads | 22 (20.4) ** | 3 (2.8) |
| Honey and bee products | 17 (15.7) *** | 1 (0.9) |
| Nuts | 12 (11.1) * | 3 (2.8) |
| Milk and dairy products | 12 (11.1) | 5 (4.6) |
| Meat and meat products | 12 (11.1) | 17 (15.7) |
| Fish and processed fish | 18 (16.7) ** | 3 (2.8) |
| Eggs | 11 (10.2) * | 2 (1.9) |
| Bread | 7 (6.5) | 14 (13.0) |
| Groats, rice, cereals | 21 (19.4) ** | 7 (6.5) |
| Flour preparations (pies, pancakes, rolls, cookies) | 18 (16.7) | 13 (12.0) |
| Sweets | 21 (19.4) | 15 (13.9) |
| Ready-made dishes for quick preparation at home | 7 (6.5) | 25 (23.1) ** |
| Coffee | 16 (14.8) | 13 (12.0) |
| Tea | 21 (19.4) ** | 6 (5.6) |
| Juices | 10 (9.3) | 12 (11.1) |
| Water | 23 (21.3) *** | 4 (3.7) |
| Alcohol | 3 (2.8) | 12 (11.1) * |
* p < 0.05, ** p < 0.01, *** p < 0.001—statistically significant differences between groups.
Changes in eating during a pandemic (n = 108).
| Parameter | Before the Pandemic | During a Pandemic |
|---|---|---|
| Number of meals during the day | ||
| 1–2 meals | 11 (10.2) | 10 (9.2) |
| 3–5 meals | 96 (88.9) | 84 (77.8) |
| over 5 meals | 1 (0.9) | 14 (13.0) |
| Time spent in front of the computer | ||
| less than 2 h a day | 59 (54.7) *** | 18 (16.7) |
| 2–3 h a day | 31 (28.7) | 15 (13.9) |
| 4–5 h a day | 10 (9.2) | 21 (19.4) |
| 6–8 h a day | 3 (2.8) | 34 (31.5) |
| more than 8 h a day | 5 (4.6) | 20 (18.5) |
| Hours of sleep per day | ||
| 6 h or less | 31 (28.7) | 33 (30.6) |
| 7–9 h | 76 (70.4) | 71 (65.7) |
| 10 or more hours | 1 (0.9) | 4 (3.7) |
*** p < 0.01—statistically significant differences between women and men.
Percentage of people by the IgG and by the rate of positive reaction after vaccination.
| Parameter | Before Vaccination ( | Before Vaccination ( | After First | After Second |
|---|---|---|---|---|
| IG | ||||
| Under 18 U/mL | 58 (53.7) | 25 (51.0) | 5 (10.2) | 0 (0.0) |
| 18–22 U/mL | 8 (7.4) | 4 (8.2) | 0 (0.0) | 0 (0.0) |
| Above 22 U/mL | 42 (38.9) | 20 (40.8) | 44 (89.8) | 49 (100.0) |
| Index of Positivity | ||||
| Under 0.9 | 58 (53.7) | 25 (51.0) | 5 (10.2) | 0 (0.0) |
| 0.9–1.1 | 8 (7.4) | 4 (8.2) | 0 (0.0) | 0 (0.0) |
| Above 1.1 | 42 (38.9) | 20 (40.8) | 44 (89.8) | 49 (100.0) |
FRAP level in the study group (n = 49).
| Parameter | Av. ± SD | Med. (Q1–Q3) |
|
|---|---|---|---|
| FRAP—before vaccination (A) | 1453.3 ± 292.2 | 1428.0 (1271.0–1599.0) | |
| FRAP—after 1 dose (B) | 1539.7 ± 285.0 | 1484.0 (1346.0–1721.0) | |
| FRAP—after 2 doses (C) | 1613.1 ± 294.4 | 1581.0 (1423.0–1787.0) |
Av.—average, FRAP—ferric reducing antioxidant power, Med.—median, Q1–Q3—quartile 1–quartile 3, SD—standard deviation.
Correlations between the selected parameters in the case of people who achieved the maximum level of IgG antibodies, and those with a lower level.
| Group | Parameter 1 | Parameter 2 | R, |
|---|---|---|---|
| IgG level below 400 | FRAP before vaccination | FRAP after first dose | 0.92, 0.0001 |
| FRAP before vaccination | FRAP after second dose | 0.93, 0.0001 | |
| FRAP after first dose | FRAP after second dose | 0.97, 0.0001 | |
| IgG before vaccination | IgG after first dose | 0.56, 0.0042 | |
| IgG before vaccination | IgG after second dose | 0.55, 0.0053 | |
| FRAP after second dose | Growth | 0.41, 0.0482 | |
| IgG level 400 | FRAP before vaccination | FRAP after first dose | 0.76, 0.0001 |
| FRAP before vaccination | FRAP after second dose | 0.78, 0.0001 | |
| FRAP before vaccination | BMI | 0.61, 0.0013 | |
| FRAP after first dose | FRAP after second dose | 0.98, 0.0001 | |
| FRAP after first dose | BMI | 0.68, 0.0002 | |
| FRAP after second dose | BMI | 0.70, 0.0001 |